Symphony Financial, Ltd. Co. Abb Vie Inc. Transaction History

Symphony Financial, Ltd. Co.

$608 Million
Q3 2024

A detailed history of Symphony Financial, Ltd. Co. transactions in Abb Vie Inc. stock. As of the latest transaction made, Symphony Financial, Ltd. Co. holds 13,480 shares of ABBV stock, worth $2.39 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

13,480

Previous 12,987 3.8%

Holding current value

$2.39 Million

Previous $2.23 Million 19.53%

% of portfolio

0.44%

Previous 0.41%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$163.84 - $199.33 $80,773 - $98,269	493 Added 3.8%	13,480 $2.66 Million
Q2 2024 Jul 17, 2024	BUY	$154.79 - $180.76 $146,895 - $171,541	949 Added 7.88%	12,987 $2.23 Million
Q1 2024 Apr 17, 2024	SELL	$159.82 - $182.1 $175,002 - $199,399	-1,095 Reduced 8.34%	12,038 $2.19 Million
Q4 2023 Jan 18, 2024	BUY	$137.6 - $154.97 $1.01 Million - $1.13 Million	7,311 Added 125.58%	13,133 $2.04 Million
Q3 2023 Nov 07, 2023	SELL	$133.59 - $154.65 $192,236 - $222,541	-1,439 Reduced 19.82%	5,822 $867,000
Q2 2023 Jul 12, 2023	SELL	$132.51 - $164.9 $106,803 - $132,909	-806 Reduced 9.99%	7,261 $978,000
Q1 2023 May 03, 2023	SELL	$144.61 - $166.54 $50,468 - $58,122	-349 Reduced 4.15%	8,067 $1.29 Million
Q4 2022 Jan 26, 2023	SELL	$138.31 - $165.87 $133,192 - $159,732	-963 Reduced 10.27%	8,416 $0
Q3 2022 Oct 27, 2022	SELL	$134.21 - $153.93 $7,381 - $8,466	-55 Reduced 0.58%	9,379 $1.34 Million
Q2 2022 Jul 18, 2022	SELL	$137.62 - $174.96 $412,584 - $524,530	-2,998 Reduced 24.12%	9,434 $1.45 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $511,158 - $634,203	3,873 Added 45.25%	12,432 $2.15 Million
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $192,407 - $243,450	1,791 Added 26.46%	8,559 $1.16 Million
Q3 2021 Oct 12, 2021	SELL	$106.4 - $120.78 $260,148 - $295,307	-2,445 Reduced 26.54%	6,768 $737,000
Q2 2021 Jul 13, 2021	BUY	$105.21 - $117.21 $69,228 - $77,124	658 Added 7.69%	9,213 $1.04 Million
Q1 2021 Apr 15, 2021	BUY	$102.3 - $112.62 $225,571 - $248,327	2,205 Added 34.72%	8,555 $902,000
Q4 2020 Jan 13, 2021	SELL	$80.49 - $108.67 $101,336 - $136,815	-1,259 Reduced 16.55%	6,350 $669,000
Q3 2020 Oct 09, 2020	BUY	$85.91 - $100.83 $6,271 - $7,360	73 Added 0.97%	7,609 $666,000
Q2 2020 Jul 08, 2020	BUY	$73.37 - $98.18 $163,615 - $218,941	2,230 Added 42.03%	7,536 $740,000
Q1 2020 May 07, 2020	BUY	$64.5 - $97.79 $342,237 - $518,873	5,306 New	5,306 $399,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Symphony Financial, Ltd. Co., based on Form 13F filings with the SEC.

News

Stay updated on Symphony Financial, Ltd. Co. with notifications on news.

Account

Symphony Financial, Ltd. Co. Abb Vie Inc. Transaction History